0001214659-22-003108.txt : 20220223
0001214659-22-003108.hdr.sgml : 20220223
20220223180325
ACCESSION NUMBER: 0001214659-22-003108
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220218
FILED AS OF DATE: 20220223
DATE AS OF CHANGE: 20220223
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: THORBURN JAMES M
CENTRAL INDEX KEY: 0001252038
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38720
FILM NUMBER: 22665400
MAIL ADDRESS:
STREET 1: C/O ZILOG INC
STREET 2: 532 RACE STREET
CITY: SAN JOSE
STATE: CA
ZIP: 95126
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Twist Bioscience Corp
CENTRAL INDEX KEY: 0001581280
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 462058888
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0930
BUSINESS ADDRESS:
STREET 1: 681 GATEWAY BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 800-719-0671
MAIL ADDRESS:
STREET 1: 681 GATEWAY BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
marketforms-55522.xml
PRIMARY DOCUMENT
X0306
4
2022-02-18
0001581280
Twist Bioscience Corp
TWST
0001252038
THORBURN JAMES M
C/O TWIST BIOSCIENCE CORPORATION
681 GATEWAY BLVD.
SOUTH SAN FRANCISCO
CA
94080
false
true
false
false
Chief Financial Officer
Common Stock
2022-02-18
4
F
false
1025
53.21
D
47925
D
Common Stock
2022-02-22
4
M
false
1517
26.66
A
49442
D
Common Stock
2022-02-22
4
M
false
2000
23.33
A
51442
D
Common Stock
2022-02-22
4
S
false
2461
52.0345
D
48981
D
Common Stock
2022-02-22
4
S
false
1341
52.8814
D
47640
D
Common Stock
2022-02-22
4
S
false
640
53.6641
D
47000
D
Employee Stock Option (right to buy)
26.66
2022-02-22
4
M
false
1517
0
D
2028-11-18
Common Stock
1517
41898
D
Employee Stock Option (right to buy)
23.33
2022-02-22
4
M
false
2000
0
D
2029-10-23
Common Stock
2000
27748
D
Represents shares withheld by the Issuer to satisfy the Reporting Person's tax withholding obligation in connection with the vesting of certain Restricted Stock Units ("RSUs") previously granted to the Reporting Person. Such withholding is exempt from Section 16(b) pursuant to Rule 16b-3(e).
The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan previously adopted by the Reporting Person on August 24, 2021.
Represents the weighted average sales price per share. The shares sold at prices ranging from $51.44 to $52.42 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Represents the weighted average sales price per share. The shares sold at prices ranging from $52.45 to $53.36 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Represents the weighted average sales price per share. The shares sold at prices ranging from $53.50 to $54.09 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
20% of the shares subject to the option vested and became exercisable on October 31, 2019, and 1/60th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
25% of the shares subject to the option vested and became exercisable on October 24, 2020, and 1/48th of the shares subject to the option vest and become exercisable on each monthly anniversary thereafter, subject to the Reporting Person's continuous service through each vesting date.
/s/ William Solis, as Attorney-in-Fact for James M. Thorburn
2022-02-23